ENSG00000125848


Homo sapiens

Features
Gene ID: ENSG00000125848
  
Biological name :FLRT3
  
Synonyms : fibronectin leucine rich transmembrane protein 3 / FLRT3 / Q9NZU0
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 20
Strand: -1
Band: p12.1
Gene start: 14322988
Gene end: 14337616
  
Corresponding Affymetrix probe sets: 219250_s_at (Human Genome U133 Plus 2.0 Array)   222853_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000339912
Ensembl peptide - ENSP00000367292
NCBI entrez gene - 23767     See in Manteia.
OMIM - 604808
RefSeq - XM_011529205
RefSeq - NM_013281
RefSeq - NM_198391
RefSeq - XM_005260682
RefSeq - XM_011529204
RefSeq Peptide - NP_037413
RefSeq Peptide - NP_938205
swissprot - Q9NZU0
Ensembl - ENSG00000125848
  
Related genetic diseases (OMIM): 615271 - Hypogonadotropic hypogonadism 21 with anosmia, 615271
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 flrt3ENSDARG00000076895Danio rerio
 FLRT3ENSGALG00000008716Gallus gallus
 Flrt3ENSMUSG00000051379Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
FLRT1 / Q9NZU1 / fibronectin leucine rich transmembrane protein 1ENSG0000012650059
FLRT2 / O43155 / fibronectin leucine rich transmembrane protein 2ENSG0000018507047
GP1BA / P07359 / glycoprotein Ib platelet alpha subunitENSG0000018524518
LRG1 / P02750 / leucine rich alpha-2-glycoprotein 1ENSG0000017123613
OMG / P23515 / oligodendrocyte myelin glycoproteinENSG0000012686112


Protein motifs (from Interpro)
Interpro ID Name
 IPR000372  Leucine-rich repeat N-terminal domain
 IPR000483  Cysteine-rich flanking region, C-terminal
 IPR001611  Leucine-rich repeat
 IPR003591  Leucine-rich repeat, typical subtype
 IPR003961  Fibronectin type III
 IPR013783  Immunoglobulin-like fold
 IPR032675  Leucine-rich repeat domain superfamily
 IPR036116  Fibronectin type III superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0003345 proepicardium cell migration involved in pericardium morphogenesis ISS
 biological_processGO:0006469 negative regulation of protein kinase activity IBA
 biological_processGO:0007155 cell adhesion IEA
 biological_processGO:0007275 multicellular organism development IEA
 biological_processGO:0007411 axon guidance IEA
 biological_processGO:0007416 synapse assembly ISS
 biological_processGO:0007507 heart development ISS
 biological_processGO:0008543 fibroblast growth factor receptor signaling pathway ISS
 biological_processGO:0019221 cytokine-mediated signaling pathway IBA
 biological_processGO:0031175 neuron projection development ISS
 biological_processGO:0046426 negative regulation of JAK-STAT cascade IBA
 biological_processGO:0048598 embryonic morphogenesis ISS
 biological_processGO:0048678 response to axon injury ISS
 biological_processGO:0050919 negative chemotaxis IEA
 biological_processGO:0051965 positive regulation of synapse assembly IEA
 biological_processGO:0060322 head development ISS
 biological_processGO:0098742 cell-cell adhesion via plasma-membrane adhesion molecules IDA
 biological_processGO:1990138 neuron projection extension ISS
 cellular_componentGO:0005576 extracellular region IEA
 cellular_componentGO:0005615 extracellular space IEA
 cellular_componentGO:0005737 cytoplasm IBA
 cellular_componentGO:0005783 endoplasmic reticulum IEA
 cellular_componentGO:0005789 endoplasmic reticulum membrane IEA
 cellular_componentGO:0005829 cytosol IDA
 cellular_componentGO:0005886 plasma membrane TAS
 cellular_componentGO:0005887 integral component of plasma membrane NAS
 cellular_componentGO:0005911 cell-cell junction IEA
 cellular_componentGO:0005925 focal adhesion IEA
 cellular_componentGO:0016020 membrane IEA
 cellular_componentGO:0016021 integral component of membrane IEA
 cellular_componentGO:0030054 cell junction IEA
 cellular_componentGO:0030424 axon IEA
 cellular_componentGO:0042995 cell projection IEA
 cellular_componentGO:0043679 axon terminus ISS
 cellular_componentGO:0044295 axonal growth cone ISS
 cellular_componentGO:0097060 synaptic membrane ISS
 molecular_functionGO:0004860 protein kinase inhibitor activity IBA
 molecular_functionGO:0005057 obsolete signal transducer activity, downstream of receptor NAS
 molecular_functionGO:0005104 fibroblast growth factor receptor binding IEA
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0030674 protein binding, bridging NAS
 molecular_functionGO:0042803 protein homodimerization activity IDA
 molecular_functionGO:0045499 chemorepellent activity IEA


Pathways (from Reactome)
Pathway description
Signaling by ROBO receptors
Downstream signaling of activated FGFR1


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000028 Cryptorchidism "Absence of one or both testes from the scrotum owing to failure of the testis or testes to descend through the inguinal canal to the testis." [HPO:curators]
Show

 HP:0000044 Hypogonadotrophic hypogonadism "Hypogonadotropic hypogonadism is characterized by reduced function of the gonads (testes in males or ovaries in females) and results from the absence of the gonadal stimulating pituitary hormones: follicle stimulating hormone (FSH) and luteinizing hormone (LH)." [HPO:curators]
Show

 HP:0000054 Micropenis 
Show

 HP:0000104 Renal agenesis 
Show

 HP:0000144 Decreased fertility 
Show

 HP:0000175 Cleft palate "Cleft palate is a developmental defect of the `palate` (FMA:54549) resulting from a failure of fusion of the palatine processes." [HPO:curators]
Show

 HP:0000365 Hearing loss 
Show

 HP:0000407 Hearing loss, sensorineural "Hearing loss caused by damage or dysfunction of the auditory nerve (cranial nerve VIII)." [HPO:curators]
Show

 HP:0000458 Anosmia "An inability to perceive odors. This is a general term describing inability to smell arising in any part of the process of smelling from absorption of odorants into the nasal mucous overlying the olfactory epithelium, diffusion to the cilia, binding to olfactory receptor sites, generation of action potentials in olfactory neurons, and perception of a smell." [HPO:curators]
Show

 HP:0000505 Impaired vision 
Show

 HP:0000508 Ptosis "Drooping of the eyelid." [HPO:curators]
Show

 HP:0000551 Abnormal color vision 
Show

 HP:0000639 Nystagmus "Rhythmic, involuntary oscillations of one or both eyes related to abnormality in fixation, conjugate gaze, or vestibular mechanisms." [HPO:curators]
Show

 HP:0000771 Gynecomastia 
Show

 HP:0000786 Primary amenorrhea 
Show

 HP:0000789 Infertility 
Show

 HP:0000823 Delayed puberty 
Show

 HP:0000830 Hypopituitarism "A condition of reduced function of the pituitary gland characterized by decreased secretion of one or more of the eight pituitary hormones." [HPO:curators]
Show

 HP:0000938 Osteopenia "Osteopenia refers to a reduction in bone mineral density (BMD) below normal peak BMD but not low enough to be classified as osteoporosis. According to the WHO, osteopenia is characterized by a value of BMD more than 1 standard deviation below the young adult mean, but less than 2 standard deviations below this value." [HPO:curators]
Show

 HP:0000939 Osteoporosis "Osteoporosis is a systemic skeletal disease characterized by low bone density and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility. According to the WHO, osteoporosis is characterized by a value of BMD 2.5 standard deviations or more below the young adult mean." [HPO:curators]
Show

 HP:0001250 Seizures "Seizures are an intermittent `abnormality of the central nervous system` (FMA:HP:0002011) due to a sudden, excessive, disorderly discharge of cerebral neurons and characterized clinically by some combination of disturbance of sensation, loss of consciousness, impairment of psychic function, or convulsive movements." [HPO:probinson]
Show

 HP:0001251 Ataxia "Ataxia is a nonspecific neurological sign and symptom consisting of gross lack of coordination of muscle movements. Ataxia is caused by dysfunction of one or more parts of the nervous system including the cerebellum, the sensory nervous system, the vestibular system, or the cerebral cortex." [HPO:curators]
Show

 HP:0001252 Muscular hypotonia "Muscular hypotonia is an abnormally low muscle tone (the amount of tension or resistance to movement in a muscle), often involving reduced muscle strength. Hypotonia is characterized by a diminished resistance to passive stretching." [HPO:curators]
Show

 HP:0001260 Dysarthria "Dysarthric speech is a general description referring to a neurological speech disorder characterized by poor articulation. Depending on the involved neurological structures, dysarthria may be further classified as spastic, flaccid, ataxic, hyperkinetic and hypokinetic, or mixed." [HPO:curators]
Show

 HP:0001288 Gait disturbance "The term gait disturbance can refer to any disruption of the ability to walk. In general, this can refer to neurological diseases but also fractures or other sources of pain that is triggered upon walking. However, in the current context gait disturbance refers to difficulty walking on the basis of a neurological or muscular disease." [HPO:curators]
Show

 HP:0001324 Muscle weakness "Reduced strength of muscles." [HPO:curators]
Show

 HP:0001335 Mirror hand movements (bimanual synkinesia) 
Show

 HP:0001337 Tremor "An unintentional, oscillating to-and-fro muscle movement." [HPO:curators]
Show

 HP:0001513 Obesity "A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY)." [MeSH:D009765]
Show

 HP:0001608 Abnormality of the voice "Any abnormality of the voice." [HPO:curators]
Show

 HP:0001761 Pes cavus 
Show

 HP:0001763 Pes planus "A condition in which the arch of the foot is flat, with the entire sole of the foot being in near-complete contact with the ground." [HPO:curators]
Show

 HP:0002215 Sparse axillary hair 
Show

 HP:0002225 Sparse pubic hair 
Show

 HP:0002652 Skeletal dysplasia 
Show

 HP:0002750 Delayed skeletal maturation "A decreased rate of skeletal maturation. Delayed skeletal maturation can be diagnosed on the basis of an estimation of the bone age from radiographs of specific bones in the human body." [HPO:curators]
Show

 HP:0002757 Recurrent fractures "The repeated occurence of bone fractures (implying an abnormally increased tendency for fracture)." [HPO:curators]
Show

 HP:0003164 Hypothalamic gonadotropin-releasing hormone (GNRH) deficiency 
Show

 HP:0003187 Breast hypoplasia 
Show

 HP:0004349 Reduced bone mineral density "A reduction of bone mineral density, that is, of the amount of matter per cubic centimeter of bones." [HPO:curators]
Show

 HP:0004409 Hyposmia "A decreased sensitivity to odorants (that is, a decreased ability to perceive odors)." [HPO:curators]
Show

 HP:0008064 Ichthyosiform abnormality of the skin 
Show

 HP:0008734 Decreased testicular size 
Show

 HP:0009804 Reduced number of teeth 
Show

 HP:0010550 Paraplegia "Severe or complete weakness of both lower extremities with sparing of the upper extremities." [HPO:curators]
Show

 HP:0030016 Dyspareunia "Recurrent or persistent genital pain associated with sexual intercourse." []
Show

 HP:0030680 Abnormality of cardiovascular system morphology "Any structural anomaly of the heart and great vessels." []
Show

 HP:0100639 Erectile abnormalities 
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000187122 SLIT1 / O75093 / slit guidance ligand 1  / reaction / complex
 ENSG00000118972 FGF23 / Q9GZV9 / fibroblast growth factor 23  / reaction / complex
 ENSG00000077782 FGFR1 / P11362 / fibroblast growth factor receptor 1  / reaction / complex
 ENSG00000133116 KL / klotho / Q9UEF7  / reaction / complex
 ENSG00000169855 ROBO1 / Q9Y6N7 / roundabout guidance receptor 1  / reaction / complex






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr